Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Claudia, Concilio"'
Autor:
Felice Gragnano, Simona Sperlongano, Enrica Golia, Francesco Natale, Renatomaria Bianchi, Mario Crisci, Fabio Fimiani, Ivana Pariggiano, Vincenzo Diana, Andreina Carbone, Arturo Cesaro, Claudia Concilio, Giuseppe Limongelli, Mariagiovanna Russo, Paolo Calabrò
Publikováno v:
Mediators of Inflammation, Vol 2017 (2017)
Beyond its role in hemostasis, von Willebrand factor (VWF) is an emerging mediator of vascular inflammation. Recent studies highlight the involvement of VWF and its regulator, ADAMTS13, in mechanisms that underlie vascular inflammation and immunothro
Externí odkaz:
https://doaj.org/article/7f7f0f03712d43b0b517a444ce155e59
Autor:
Agostino Mattera, Vincenzo Coscia, Marcello Brignoli, Angela Fusco, Claudia Concilio, Raffaele Chianese, Alfonso De Michele, Ivana Pariggiano, Vincenzo Diana, Miguel Viscusi, Paolo Calabrò
Publikováno v:
European Heart Journal Supplements. 23
Aims Cardiac amyloidosis (CA) is primarily associated with fibril deposits in many cardiac structures, causing biventricular wall thickness and stiffness. CA may result in arrhythmias and particularly in an aggressive form of heart failure (HF). Card
Autor:
Giuseppe Pacileo, Arturo Cesaro, Francesco Natale, Claudia Concilio, Elisabetta Moscarella, Francesco Pelliccia, Eduardo Bossone, Marina Verrengia, Paolo Calabrò, Fabiana De Simone, Emanuele Monda, Augusto Esposito, Daniele Masarone, Vittorio Pazzanese, Giuseppe Limongelli, Martina Caiazza, Felice Gragnano, Fabio Valente
Publikováno v:
European Journal of Preventive Cardiology. 27:1906-1908
Autor:
Fabio Fimiani, Giuseppe Limongelli, Arturo Cesaro, Eduardo Bossone, Elisabetta Moscarella, Felice Gragnano, Vincenzo Diana, Francesco Natale, Ivana Pariggiano, Paolo Calabrò, Claudia Concilio
Publikováno v:
European Journal of Preventive Cardiology. 27:556-558
Autor:
Felice Gragnano, Marco Di Maio, Arturo Cesaro, Elisabetta Moscarella, Plinio Cirillo, Claudia Concilio, Paolo Calabrò, Dario Di Maio, Fabio Fimiani, Mario Crisci, Vittorio Taglialatela, Ivana Pariggiano, Vincenzo Diana
Background: Dual antiplatelet therapy (DAPT) with aspirin and ticagrelor is recommended for at least 12 months in patients after an acute coronary syndrome (ACS). However, its underuse and premature discontinuation are common in clinical practice. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d49fabf88ec8eb57872f7f5f995e0fc
http://hdl.handle.net/11588/815750
http://hdl.handle.net/11588/815750
Autor:
Domenico Di Girolamo, Felice Gragnano, Francesco Cesaro, Elisabetta Moscarella, Arturo Cesaro, Giuseppe Limongelli, Claudia Concilio, Sergio Falato, Vincenzo Diana, Alfonso Alfieri, Ivana Pariggiano, Rocco Perrotta, Paolo Calabrò, Giuseppe Mercone, Augusto Esposito
Introduction: The radial artery is currently the most widely used access site for PCI procedures both acute and stable patient settings. Thanks to advantages in pharmacological therapy as well as in interventional devices, the rate of ischemic compli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e737b3088dbd0ab46b82d9d7760f4963
http://hdl.handle.net/11591/436019
http://hdl.handle.net/11591/436019
Autor:
Mario Crisci, Francesco Natale, Felice Gragnano, Enrica Golia, Marcello Arca, Arturo Cesaro, Giuseppe Limongelli, Mariagiovanna Russo, Rossella Sperlongano, Simona Sperlongano, Claudia Concilio, Fabio Fimiani, Paolo Calabrò, Laura D'Erasmo
Publikováno v:
Journal of cardiovascular medicine (Hagerstown, Md.). 19(3)
Aims: Homozygous familial hypercholesterolemia (HoFH) is a genetic dyslipidemia characterized by elevated levels of low-density lipoprotein cholesterol (LDL-C) and accelerated atherosclerosis. Frequently, traditional lipid-lowering therapy is ineffec
Autor:
Arturo Cesaro, Mariagiovanna Russo, Claudia Concilio, Mario Crisci, Francesco Natale, Maurizio Cappelli Bigazzi, Ivana Pariggiano, Giuseppe Limongelli, Felice Gragnano, Renatomaria Bianchi, Fabio Fimiani, Vincenzo Diana, Enrica Golia, Paolo Calabrò, Plinio Cirillo, Simona Sperlongano
von Willebrand Factor (vWF) is a well-known mediator of hemostasis and vascular inflammation. Its dynamic modulation in the bloodstream, according to hemodynamic conditions, makes it an appealing biomarker in patients with valvular heart disease (VHD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8314c46b9cf0a0db3940ea56ee204ccc
http://hdl.handle.net/11588/707802
http://hdl.handle.net/11588/707802
Autor:
Mario Crisci, Arturo Cesaro, Enrica Golia, Giuseppe Limongelli, Claudia Concilio, Mariagiovanna Russo, Fabio Fimiani, Felice Gragnano, Francesco Natale, Raffaele Calabrò, Paolo Calabrò, Simona Sperlongano
Publikováno v:
Journal of cardiovascular medicine (Hagerstown, Md.). 19(2)
Autor:
Mario Crisci, Francesco Natale, Fabio Fimiani, Paolo Calabrò, Arturo Cesaro, Enrica Pezzullo, Felice Gragnano, Simona Sperlongano, Raffaele Calabrò, Claudia Concilio, Mariagiovanna Russo
Publikováno v:
European Heart Journal. 38